Okosieme Onyebuchi E, Lazarus John H
a Endocrinology and Diabetes Department, Prince Charles Hospital, Cwm Taf Local Health Board, Merthyr Tydfil, Mid Glamorgan, CF47 9DT, UK.
b Centre for Endocrine and Diabetes Sciences, School of Medicine, Cardiff University, Cardiff CF14 4XN, South Wales, UK.
Expert Rev Endocrinol Metab. 2010 Jul;5(4):521-529. doi: 10.1586/eem.10.30.
Recent decades have seen a growing awareness of the threat posed by thyroid dysfunction in pregnancy on maternal, fetal and neonatal well-being. Uncontrolled hypothyroidism and hyperthyroidism are associated with adverse obstetrics and fetal outcomes and also affect neurointellectual development in the offspring. Excellent outcomes are, however, achievable with appropriate management. An understanding of the changes in thyroid hormone economy in pregnancy is crucial to the evaluation of thyroid status in pregnant patients with thyroid dysfunction. Furthermore, a balance must be maintained between the control of maternal disease and the requirements of the developing fetus. Careful monitoring of patients in a multidisciplinary care setting, and appropriate adjustments of treatment, is essential throughout pregnancy and the puerperium. In this special report we summarize best practice in the management of thyroid dysfunction in pregnancy.
近几十年来,人们越来越意识到孕期甲状腺功能障碍对孕产妇、胎儿和新生儿健康构成的威胁。未得到控制的甲状腺功能减退和甲状腺功能亢进与不良的产科和胎儿结局相关,还会影响后代的神经智力发育。然而,通过适当的管理可以取得良好的结局。了解孕期甲状腺激素代谢的变化对于评估患有甲状腺功能障碍的孕妇的甲状腺状态至关重要。此外,必须在控制母体疾病和发育中胎儿的需求之间保持平衡。在整个孕期和产褥期,在多学科护理环境中对患者进行仔细监测并适当调整治疗至关重要。在本特别报告中,我们总结了孕期甲状腺功能障碍管理的最佳实践。